ANRO
Alto Neuroscience, Inc.
NYSE: ANRO · HEALTHCARE · BIOTECHNOLOGY
$25.80
+6.15% today
Updated 2026-04-30
Market cap
$859.49M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.19
Dividend yield
—
52W range
$2 – $28
Volume
0.3M
Alto Neuroscience, Inc. (ANRO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-41.80%
ROA
-22.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | $210000.00 | $-9.19M | 30.95% | -5,740.95% | -4,374.76% |
| 2022 | $0.00 | $-27.71M | — | — | — |
| 2023 | $0.00 | $-36.30M | — | — | — |
| 2024 | $0.00 | $-61.43M | — | — | — |
| 2025 | $0.00 | $-63.24M | — | — | — |